Alterity Therapeutics (ATHE) Operating Income (2009 - 2019)
Alterity Therapeutics (ATHE) posted quarterly Operating Income of -$3.9 million for Q4 2019, up 11.17% quarter-over-quarter from -$4.3 million in Q2 2010.
Alterity Therapeutics (ATHE) Operating Income (2009 - 2019) Analysis & Trends
Alterity Therapeutics' Operating Income history runs 3 years deep, the most recent figure standing at -$3.9 million for Q4 2019.
- In Q4 2019, Operating Income changed N/A year-over-year to -$3.9 million; the TTM figure through Dec 2019 stood at -$26.7 million (changed N/A YoY), while the FY2012 annual figure was $204574.6, up 20.51% from the prior year.
- Operating Income for Q4 2019 stood at -$3.9 million, up from -$4.3 million in the prior quarter.
- The five-year high for Operating Income was -$3.9 million in Q4 2019, with the low at -$3.9 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.39 Bn | 132.54 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.47 Bn | 78.47 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 61.79 Bn | 56.66 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 42.27 Bn | 37.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.17 Bn | 27.86 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 28.61 Bn | 10.22 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 133.12 Mn |
| 10 | Alterity Therapeutics | 50.86 Mn | 18.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -3.85 Mn |
| Jun 30, 2010 | -4.34 Mn |
| Jun 30, 2009 | -5.71 Mn |